FindTrial
Sign In

A new-type hysteroscopic morcellator in treatment of interuterine benign pathologies

A clinic trial of hysteroscopic morcellator in treatment of submucosal fibroids, utrine polyps and placenta remnants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009074
Enrollment
Unknown
Registered
2016-08-24
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal Fibroids, uterine polyps, placental remnants

Interventions

morcellation group:hysteroscopic morcellation
resection group:hysteroscopic monopolar loop resection

Sponsors

GuangDong Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. 18 Years and older, willing to participate in the study and sign the consent form; 2. The diameters of interuterine tissues were on more than 5cm; 3. Type 0/1 or type 2 submucosal fibroids extending to myometrium for no more than 70%.

Exclusion criteria

Exclusion criteria: 1. Multiple submucosal fibroids; 2. The diameters of interuterine tissues were more than 5cm; 3. Type 2 submucosal fibroids extending to myometrium for more than 70%; 4. Suspected malignancy.

Design outcomes

Primary

MeasureTime frame
dilation time;operation time;—

Secondary

MeasureTime frame
distension fluid deficit;amount of bleeding;complication;postoperative adhesions rate;postoperative pregnancy rate;—

Countries

China

Contacts

Public ContactLiqin Zeng

GuangDong Women and Children Hospital

zenglq89@163.com+86 18602075356

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026